UTIAMC2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member UTIAMC2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member UTIAMC2022-10-012022-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member UTIAMC2022-10-012022-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares UTIAMC 2022-04-01 2023-03-31 2022-12-21 INR Crores Third quarter false Single segment The Company is in the business of providing asset management services to UTI Mutual Fund and portfolio management & advisory services to clients & providing Point of Presence service to NPS subscriber. The primary segment is identified as asset management services and accordingly there are no separate reportable segments as per Ind AS 108 - Operating Segment. 2022-10-01 2022-12-31 Unaudited Standalone 79300000.00 0.00 32000000.00 0.00 432100000.00 0.00 0.00 2261500000.00 2804900000.00 900000.00 2805800000.00 0.00 0.00 0.00 897700000.00 24500000.00 97400000.00 25300000.00 0.00 0.00 0.00 297700000.00 1342600000.00 1463200000.00 0.00 1463200000.00 320000000.00 61600000.00 381600000.00 1081600000.00 0.00 0.00 0.00 0.00 1081600000.00 15700000.00 1097300000.00 1097300000.00 0.00 1269700000.00 10 8.52 8.52 0.00 0.00 8.52 8.52 0.00 0.00 0.00 Notes: 1. The standalone financial results of UTI Asset Management Company Limited (the Company) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 - Interim Financial Reporting, notified under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. 2. The Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held on September 13, 2022 had approved grant of 10,17,243 stock options representing 10,17,243 equity shares of Rs 10 each, at a grant price of Rs 816.05 per equity share (being the market price as defined in the applicable SEBI Regulations), to the eligible employees of the Company and its subsidiaries under “UTI AMC Employee Stock Option Scheme -2007”. 3. During the quarter and nine months ended December 31, 2022, the Company has allotted 4,427 equity shares and 17,044 equity shares of face value Rs 10 each, respectively, pursuant to exercise of stock options. 4. During the nine months period ended December 31, 2022, the Company paid a final dividend of Rs. 21 per equity share (Previous Year Rs.17 per share) for the year ended March 31, 2022 as approved by the shareholders at the Annual General Meeting held on July 25, 2022. 5. The Company is in the business of providing asset management services, portfolio management, advisory services and providing Point of Presence service to NPS subscriber. The primary segment is identified as asset management services. As such, the Company's financial results are largely reflective of asset management business, accordingly, there are no separate reportable segments as per Ind AS 108 - Operating Segments. 6. During the quarter ended September 30, 2022, the Company had subscribed to equity shares of UTI Capital Private Limited on a right issue basis and been alloted 10,633,584 equity shares at an offer price of Rs. 22.57 per equity share amounting to Rs. 24 Crore. 7. UTI Investments America Limited has been incorporated on November 7, 2022 as a Wholly Owned Subsidiary ('WOS') of UTI International Limited (WOS of the Company). The WOS is in the process of capitalisation as at December 31, 2022. 8. The outbreak of COVID - 19 pandemic has affected several countries across the world, including India, resulting in significant volatility in financial market and significant decrease in global and Indian economy. The Government is undertaking several measures to restrict the spread of virus and provide financial support to some stressed sectors. While the situation had improved significantly and there had been an all-round recovery in economic activity, the situation will have to be closely monitored till the pandemic is finally put to rest. Management will continue to closely monitor the material changes in the macro-economic factors impacting the operations of the Company. 9. The above results for the quarter and nine months ended December 31, 2022, which have been subjected to a Limited Review by the Statutory Auditors of the Company, have been reviewed by the Audit Committee of the Board of Directors and subsequently approved by the Board of Directors at its meeting held on February 01, 2023, in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 10. Previous period’s/year’s figures have been regrouped / reclassified wherever necessary, to conform to current period’s presentation. 11. Earnings per equity share for interim period is not annualised. Single segment 2022-04-01 2022-12-31 Unaudited Standalone 140100000.00 0.00 98800000.00 0.00 1125800000.00 0.00 0.00 6952000000.00 8316700000.00 9900000.00 8326600000.00 0.00 0.00 0.00 2660200000.00 71000000.00 282300000.00 72900000.00 0.00 0.00 0.00 925100000.00 4011500000.00 4315100000.00 0.00 4315100000.00 940000000.00 81700000.00 1021700000.00 3293400000.00 0.00 0.00 0.00 0.00 3293400000.00 160700000.00 3454100000.00 3454100000.00 0.00 1269700000.00 10 25.94 25.93 0.00 0.00 25.94 25.93 0.00 0.00 0.00 Other Expenses 297700000.00 Other Expenses 925100000.00 0.00 0.00 0.00 0.00 15700000.00 160700000.00